Councils - Pulmonary Hypertension
SCIENTIFIC COUNCIL ON PULMONARY HYPERTENSION Council Leadership Operating Board:COUNCIL CHAIR:
Tuesday, April 14, 2015
for more details.
April 15-18, 2015
Nice, FRANCETuvia Ben Gal, MD
, Petah Tikva, ISRAELTeresa De Marco, MD, FACC
, San Francisco, CA, USAAndrew J. Fisher, FRCP, PhD
(2016 Program Chair), Newcastle Upon Tyne, UKNicolas Manito, MD
, Barcelona, SPAINMandeep R. Mehra, MD, MBBS, FACC, FACP
(Journal Editor), Boston, MA, USACarmine Dario Vizza, MD
, Rome, ITALY
for more details.
The ISHLT is pleased to announce the . Click HERE
University of Chicago
Chicago, Illinois, USA
email@example.comMardi Gomberg-Maitland, MD, MSc, is Associate Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Chicago Medical Center. She is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multi-national research trials to explore new therapies for pulmonary hypertension. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently focusing on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, and biomarker development. Dr. Gomberg-Maitland attended medical school at the Albert Einstein College of Medicine in New York. She completed her residency at the New York Presbyterian Hospital-Weill/Cornell Medical Center and a fellowship at Mount Sinai Medical Center in New York. In addition, she has earned a Masters in Clinical Epidemiology from Harvard School of Public Health in Boston, Massachusetts. She is board certified in Internal Medicine and Cardiology.COUNCIL VICE CHAIR:
Kaiser San Francisco
San Francisco, California, USA
firstname.lastname@example.orgDr. Dana McGlothlin obtained her undergraduate and medical degrees at the University of Kansas before heading west to the Mayo Clinic in Arizona, where she completed her internal medicine residency and cardiology fellowship. She then joined the faculty at the University of California San Francisco after completing an advanced fellowship in echocardiography in 2003. While at UCSF, she developed an interest and expertise in pulmonary hypertension, cardiac amyloidosis, advanced heart failure, heart transplantation, and mechanical assist devices, although she enjoy all aspects of cardiology care, including prevention and treatment of all of the more common cardiovascular diseases.COUNCIL PAST CHAIR:
Rochester, Minnesota, USA
email@example.comRobert P. Frantz, MD, FACC, is Director of the Pulmonary Hypertension Clinic at the Mayo Clinic in Rochester, Minnesota, and Associate Professor of Medicine at the College of Medicine, Mayo Clinic. Primary interests include pulmonary hypertension both WHO Group I, and also associated with left heart disease and in context of MCS and transplantation. He performs hemodynamic assessments including exercise and drug interventions in the catheterization laboratory for patients with PAH, left heart disease, and MCS. Clinical responsibilities include management of cardiac transplant candidates and recipients, PAH, advanced left heart disease, and MCS recipients. Dr. Frantz graduated cum laude (Biochemistry) from Harvard University, Cambridge MA. He received his medical degree from Mayo Medical School, Rochester MN and completed Internal Medicine residency at the Mayo Graduate School of Medicine. After completing fellowship in Cardiovascular Diseases at University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, Dr. Frantz joined the staff of the Mayo Clinic in 1990. Dr. Frantz is board certified in cardiology and internal medicine.COUNCIL WORKFORCE LEADERS:
Hammersmith Hospital, Department of Cardiology
London, UNITED KINGDOM
firstname.lastname@example.orgBio coming soon...
Inova Fairfax Hospital
Falls Church, VA, USA
703-776-2256Oksana.Shlobin@inova.orgOksana A. Shlobin, MD, FCCP, is a co-director of the Inova Pulmonary Hypertension Program and an assistant director of Inova Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, Falls Church, VA. She is an Associate Clinical Professor of Medicine at Georgetown University School of Medicine and Assistant Clinical Professor of Medicine at Virginia Commonwealth University School of Medicine. Dr. Shlobin received her medical degree from Georgetown University School of Medicine in Washington, DC. She completed her internship and residency in internal medicine at Harvardís Beth Israel Deaconess Medical Center in Boston. Dr. Shlobin completed her fellowship in pulmonary and critical care medicine at Johns Hopkins University Hospital in Baltimore, MD. She is board certified in pulmonary medicine and critical care medicine. Dr. Shlobin is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. She is a member of several professional medical associations, including the ISHLT, ATS, ACCP and the AOA.COUNCIL LIAISONS:
University of Maryland School of Medicine
Baltimore, MD, USA
email@example.comDr. Myung Park is Associate Professor of Medicine and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. Her focus of interest in research and clinical practice is in Pulmonary Hypertension. She completed her MD and residency from Temple University School of Medicine, and completed a fellowship in Heart Failure & Cardiac Transplant at the Cleveland Clinic, and a fellowship in Cardiovascular Diseases at the Medical College of Virginia Hospitals.
Allegheny General Hospital
Pittsburgh, PA, USA
firstname.lastname@example.org Bio coming soon...
Ohio State University
Columbus, Ohio, USA
email@example.comVeronica Franco, MD, FACC, is director of the Exercise Physiology/Metabolic Exercise Testing Program and Head of Pulmonary Hypertension Research for the division of Cardiology. Her expertise is in pulmonary arterial hypertension, right ventricular failure, advanced heart failure, cardiac transplant, and mechanical support of the heart. She is an assistant professor of clinical medicine at The Ohio State University Medical Center. Dr. Franco earned her medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru. She completed her residency in internal medicine from the University of Alabama at Birmingham. She received her Cardiovascular Medicine Fellowship training at the University of Alabama at Birmingham with subspecialty training in Pulmonary vascular disease, Heart Failure and Cardiac Transplantation which was completed in 2007. Dr. Franco also obtained a Masters in Clinical Research and Statistics at the same institution's School of Public Health. Further, Dr. Franco completed a research fellowship in the Vascular Biology and Hypertension Program at the University of Alabama at Birmingham. Dr. Franco actively participates in clinical and research activities for patients with pulmonary hypertension and advanced heart failure. Dr. Franco's research interests are in right ventricular failure, pulmonary arterial hypertension and mechanical circulatory support of the heart using left ventricular assist devices (LVADs). She is also interested in investigating cardiopulmonary exercise testing in patients with right or left ventricular heart failure.
Indiana University Health
Indianapolis, IN, USAmcaccamo@iuhealth.orgMarco Caccamo, DO, is an Assistant Professor of Medicine at Indiana University School of Medicine. He completed his residency training at the Cleveland Clinic in 2009. Dr. Caccamo then moved to Minneapolis, Minnesota where he completed his cardiology training at the University of Minnesota in 2012. He then completed an additional year in advanced heart failure and pulmonary hypertension at Allegheny General Hospital in Pittsburgh, PA. His clinical interests include pulmonary hypertension, mechanical circulatory support and cardiac transplantation.